Skip to main content

Verteporfin Dosage

Medically reviewed by Last updated on Jul 5, 2023.

Applies to the following strengths: 15 mg

Usual Adult Dose for Macular Degeneration

6 mg/m2 IV over 10 minutes once; this drug is photoactivated by 83 seconds of laser light administration (689 nm) commencing 15 minutes after start of the infusion

A course of therapy is a 2-step process requiring administration of both drug and light. The first step is the IV infusion of this drug. The second step is the activation of the drug with light from a nonthermal diode laser. The physician should reevaluate the patient 3 months after treatment and if choroidal neovascular leakage is detected on fluorescein angiography, therapy may be repeated.

Lesion Size Determination:

Spot Size Determination:


Uses: For the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia, or presumed ocular histoplasmosis

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available



Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.


Data not available

Other Comments


Storage requirements:

Reconstitution/preparation techniques/IV Compatibility:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.